Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 4, 2007, Pages 681-686

  Dutta, Tathagata ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Anti HIV activity; Lamivudine; Macrophage Targeting; Mannosylated dendrimer; Poly (propyleneimine) dendrimer

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CONCANAVALIN A; DENDRIMER; IMINE; LAMIVUDINE; MANNOSE; POLYMER; POLYPROPYLENE;

AGGLUTINATION TEST; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AGGLUTINATION; ANTI-HIV AGENTS; CALMODULIN; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; HIV CORE PROTEIN P24; HIV-1; HUMANS; LAMIVUDINE; LYMPHOCYTES; REVERSE TRANSCRIPTASE INHIBITORS; SCHIZOSACCHAROMYCES POMBE PROTEINS; SOLUBILITY; TIME FACTORS;

EID: 33847174124     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.12.007     Document Type: Article

References (33)

1. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57 (1993) 183-289
2. Weiss R.A. How does HIV cause AIDS. Science 260 (1993) 1273-1279
3. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 (1986) 215-219
4. Nicholson J.K., Cross G.D., Callaway C.S., and Mc Dougal J.S. In vitro infection of human monocytes with human T-lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV). J. Immunol. 137 (1986) 323-329
5. Von Briesen H., Andreesen R., Esser R., Brugger W., Meichisner C., Becker K., and Rubsamen-Waigmann H. Infection of monocytes-marophages by HIV in vitro. Res. Virol. 141 (1990) 225-231
6. Pr3TC, lamivudine GlaxoSmithkline Shire Biochem, Ontario, L5N 6L4, August 24 (2004) 1-36.
7. Thomas S.A. Anti-HIV drug distribution to the central nervous system. Curr. Pharm. Design. 10 (2004) 1313-1324
8. Auger M.J., and Ross J.A. In: Lewis C.E., and Mcgee J.O.D. (Eds). The Natural Immune System: The Macrophage (1992) 2-74
9. Liu M.J., and Frechet J.M.J. Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 2 (1999) 393-401
10. Shakthivel T., and Florence A.T. Dendrimers and dendrons: facets of pharmaceutical nanotechnology. Drug Deliv. Technol. 3 (2003) 73-78
11. Tomalia D.A. Birth of a New Macromolecular Architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta 37 2 (2004) 39-57
12. Virad M., Paolini I., Rawat S., Fechhi K., Sargiacomo M., Puri A., and Blumenthal R. The role of glycosphingolipids in HIV signaling entry and pathogenesis. Glycoconj. J. 20 3 (2004) 213-222
13. Zhao H., Li J., Xi F., and Jiang L. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR. RNA 563 (2004) 241-245
14. Rosa Borges A., and Schengrund C.L. Dendrimers and antivirals: a review, current drug targets-infect. Disorders 5 (2005) 247-254
15. Bernstein D.I., Ayisi N.K., Ireland J., Matthews B., McCarthy T., and Sacks S. Evaluation of formulated dendrimer SPL7013 as a microbicide. Antivir. Res. 57 3 (2003) 89
16. Schafer V., Von Briesen H., Andreesen R., Steffan A.M., Royer C., Troster S., Kreuter J., and Rubsamen-Waigmann H. Phagocytosis of nanoparticles by Human Immunodeficiency virus (HIV) infected macrophages: a possibility for antiviral drug targeting. Pharm. Res. 9 4 (1992) 541-546
17. Betageri G.V., Black C.D.V., Szenbeni J., Wahl L.M., and Weinstein J.N. Fc receptor mediated targeting of antibody bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages. J. Pharm. Pharmacol. 45 (1993) 48-53
18. Bender A.R., Von Briesen H., Kreuter J., Duncan I.B., and Rubsamen-Waigmann H. Efficiency of nanoparticles as carrier systems for antiviral agents in human immunodeficiency virus infected human monocytes/macrophages in vitro. Antimicrob. Agents Chemother. 40 6 (1996) 1467-1471
19. Jansen J.P.G.A., Brabender-Van Den Berg E.M.M., and Meijer E.W. Encapsulation of guest molecules into a dendritic box. Science 226 (1994) 1226-1229
20. De Brabender Van Den Berg E.M.M., and Meijer E.W. Poly (propylene) imine dendrimers. Large scale synthesis by heterogeneously catalyzed hydrogenation. Angew. Chem., Int. Ed. Engl. 32(a) (1993) 1308-1311
21. Dutta T., Agashe H.B., Garg M., Balasubramanium P., Kabra M., and Jain N.K. Poly(propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J. Drug Target. 15 1 (2007) 1-12
22. Ashton P.R., Boyd S.E., Brown C.L., Nepogodier S.A., Meijer E.W., Peerlings H.W.I., and Stoddart J.F. Synthesis of glycodendrimers by modification of poly(propylene) imine dendrimers. Chem. Eur. J. 3 6 (1997) 974-984
23. Miklis P., Cogin T., and Goddard W.A. Dynamics of Bengal Rose encapsulated in Meijer's Dendrimer box. J. Am. Chem. Soc. 119 (1997) 7458-7462
24. Bhadra D., Yadav A.K., Bhadra D., and Jain N.K. Glycodendrimeric nanoparticulate carriers of primaquin phosphate for liver targeting. Int. J. Pharm. 295 (2005) 221-233
25. Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., Tyler P.C., and Davies N.M. Liposomal delivery of antigen to human dendritic cells. Vaccine 21 (2003) 883-890
26. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., and Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and haemolysis. Biomaterials 24 (2003) 114-1131
27. 125I labeled polyamidoamine dendrimers in vivo. J. Control. Release 65 (2000) 133-148
28. Staszewski S., Morates-Ramirez J., Tashima K.T., Rachilis A., Skiest D., Stanford J., Stryker R., Johnson P., Labriola D.F., Farinal D., Minion D.J., and Ruiz N.M. Efavirenz plus Zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus Zidovudine and lamivudine in the treatment of HIV 1 infection in adults. N. Engl. J. Med. 341 (1999) 1865-1873
29. Konopka K., Davis B.R., Larsen C.E., Alford D.R., Debs R.J., and Duzgunes N. Liposomes modulate human immunodeficiency virus infectivity. J. Gen. Virol. 71 (1990) 2899-2907
30. Jevprasesphant R., Penny J., Jalal R., Attwood D., Mc Keown N.B., and D'Emanuel A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int. J. Pharm. 252 1-2 (2003) 263-266
31. Mankertz J., Matthes E., Rokos K., von Bayer H., Pauli G., and Riedel E. Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells. Biochem. Biophys. Acta 1317 (1996) 233-237
32. Fridkin M., Tsubery H., Tzehoval E., Vonsover A., Biondi L., Filira F., and Rocchi R. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy. J. Pept. Sci. 11 (2005) 37-344
33. Fridkin M., and Najjar V.A. Tuftsin: its chemistry, biology and clinical potential. Crit. Rev. Biochem. Mol. Biol. 24 1 (1989) 1-33